
Every component, on the record.
Each vial in the set ships from the lot shown here, with its own certificate.
Independent lab: Kalbio Biotechnology, Lake Forest CA · ISO/IEC 17025 · All lab reports
About this set.
A three-vial metabolic set combining the triple GIP/GLP-1/glucagon agonist Retatrutide, the long-acting amylin analog Cagrilintide, and the lipolytic hGH fragment AOD-9604. Retatrutide is offered at 10, 20 or 30 mg and Cagrilintide at 5 or 10 mg, giving six configurations.
- Multi-receptor metabolic signalling
- Satiety & energy-balance models
- Comparative agonist studies
| Family | Triple-Agonist Metabolic Set |
|---|---|
| Purity | ≥98% per component |
Storage & handling
Store at −20°C, protected from light. Shipped cold, sealed against light and moisture. Full guidance on the handling page.
Shipping
Dispatched within 1–2 business days, packed cold. Free cold-chain shipping on orders over $150; otherwise $9.99. Details in the shipping policy.
Returns & damage
Damaged or incorrect? Email us within 48 hours of delivery with a photo and we will replace it. See the returns policy.
Research-use policy
Sold strictly for in-vitro laboratory research. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease. Purchasers must be 21+.



